Delivery Order SPE2DB20D2104-SPE2DB25FMRVW

Award Date 5/28/25
Potential Completion Date 5/29/25
Potential Value $2.9K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of 4,568,092,038 units of the BOOSTRIX TDAP vaccine syringe (0.5 mL). The contract has a firm fixed price of $16,764.30 and a completion date of May 1, 2025. This contract is not set aside and was competitively awarded. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the...
This is a delivery order under contract SPE2DB20D2002|SPE2DB23FL30D, awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $25,492 firm fixed-price contract is for the delivery of 4,560,472,166 units of the BOOSTRIX TDAP VACCINE SYRINGE 0.5ML. The contract has an ultimate completion date of March 31, 2023 and is not designated as a set-aside. AmerisourceBergen holds a $999,999,999 Indefinite...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,064.40, is for the delivery of 4,568,032,429 units of the BOOSTRIX TDAP vaccine syringe (0.5 mL). The contract is a firm fixed-price, non-set-aside delivery order with an ultimate completion date of April 28, 2025. AmerisourceBergen Drug Corp holds a significant Indefinite...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of 4,568,150,456 units of the BOOSTRIX TDAP vaccine syringe (0.5mL). The contract has a ceiling value of $3,546.48 and is a firm fixed-price, non-set-aside contract with a period of performance through May 7, 2025. AmerisourceBergen Drug Corp holds a larger Indefinite Delivery Contract (IDC) valued at $999,999,999.00 with the DLA Troop...
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, the prime contractor. The contract, which has a potential value of $3,771.04, is for the supply of 4,563,472,692 BOOSTRIX TDAP vaccine syringes (0.5ml). The contract has a completion date of January 30, 2024 and was awarded on January 29, 2024. Amerisourcebergen Drug Corp, a for-profit organization, is a subsidiary of Amerisourcebergen Corporation, a...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,198.92, is for the delivery of BOOSTRIX TDAP VACCINE SYRINGE 0.5ML to support military healthcare programs. The contract has a firm fixed price pricing type and an ultimate completion date of May 10, 2023. AmerisourceBergen Drug Corp is the prime contractor,...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the provision of 4,560,911,316 units of the BOOSTRIX TDAP Vaccine Syringe 0.5mL. The contract has a firm fixed price of $3,347.23 and a completion date of May 12, 2023. This delivery order is part of a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. The IDC serves as a...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of BOOSTRIX TDAP VACCINE SYRINGE 0.5ML, a vaccine product. The contract has a firm fixed price of $24,653.41 and a period of performance through April 21, 2025. This contract is not set-aside and was awarded through open competition. AmerisourceBergen Drug Corp holds a larger Indefinite...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of 4,566,446,070 units of the BOOSTRIX TDAP vaccine syringe (0.5 ml). The firm-fixed-price contract is valued at $1,053.96 and has an ultimate completion date of November 18, 2024. The contract is not designated as a set-aside. AmerisourceBergen, a for-profit organization registered in the System for Award Management (SAM.gov), holds a...
This is a delivery order under a larger Indefinite Delivery Contract (IDC) awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp's Corporate Office division. The order is for 4,565,365,606 units of the BOOSTRIX TDAP vaccine syringe, a 0.5 mL dose of the tetanus, diphtheria, and acellular pertussis vaccine. The contract has a firm fixed price of $1,877.65 and a completion date of August 7, 2024. AmerisourceBergen is a major pharmaceutical distributor...
  • SPE2DB20D2104
    Indefinite Delivery Contract
  • SPE2DB20D2104-SPE2DB25FMRVW
    Delivery Order

This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,568,369,386 units of the BOOSTRIX TDAP VACCINE SYRINGE 0.5ML product. The contract has a firm-fixed price of $2,890.36 and a completion date of May 29, 2025. Amerisourcebergen Drug Corp is the prime contractor, and there is no set-aside designation for this contract. The contract is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999.00 that Amerisourcebergen holds with the DLA Troop Support Medical, which provides a comprehensive global pharmaceutical support vehicle for the military healthcare programs of the Defense Health Agency, U.S. Coast Guard, and other government agencies.

Generated 8/31/25, 1:03 AM